BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36444880)

  • 1. Monitoring of molecular profiling of allergen-antibody responses in HDM-immunotherapy patients.
    Nittner-Marszalska M; Kopeć A; Foks-Ciekalska A; Lata A; Bogacz-Piaseczyńska A; Rosiek-Biegus M; Zajac M; Bożek A
    Hum Vaccin Immunother; 2022 Dec; 18(7):2148815. PubMed ID: 36444880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dust mite component Analysis: Identifying key allergens components for effective immunotherapy in allergic rhinitis.
    Huang J; Xiang R; Tan L; Deng Y; Tao Z; Zhang W; Xu Y
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111111. PubMed ID: 37925948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific IgE and IgG4 Profiles of House Dust Mite Components in Allergen-Specific Immunotherapy.
    Yang L; Yang Y; Xu Q; Zhang W; Jiang Q; Li W; Wang Y; Ma D; Lin X; Sun B; Zhu R
    Front Immunol; 2021; 12():786738. PubMed ID: 35197963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of immunotherapy on cross-reactivity between house dust mite and other allergens in house dust mite -sensitized patients with allergic rhinitis.
    Zhao L; Zhang Y; Zhang S; Zhang L; Lan F
    Expert Rev Clin Immunol; 2021 Sep; 17(9):969-975. PubMed ID: 34388949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Profile Sensitization to House Dust Mites as an Important Aspect for Predicting the Efficiency of Allergen Immunotherapy.
    Rodinkova VV; Yuriev SD; Kryvopustova MV; Mokin VB; Kryzhanovskyi YM; Kurchenko AI
    Front Immunol; 2022; 13():848616. PubMed ID: 35392080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy.
    Rodríguez-Domínguez A; Berings M; Rohrbach A; Huang HJ; Curin M; Gevaert P; Matricardi PM; Valenta R; Vrtala S
    J Allergy Clin Immunol; 2020 Nov; 146(5):1097-1108. PubMed ID: 32298697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular reactivity profiling upon immunotherapy with a 300 IR sublingual house dust mite tablet reveals marked humoral changes towards major allergens.
    Potapova E; Bordas-Le Floch V; Schlederer T; Vrtala S; Huang HJ; Canonica GW; Valenta R; Matricardi PM; Mascarell L
    Allergy; 2022 Oct; 77(10):3084-3095. PubMed ID: 35474582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological analysis of allergic components of house dust mite provides more insight in epidemiological characteristics and clinical symptom development in North China.
    Liu Y; Zhao L; Wang J; Guo Y; Wang Y; Zhang L; Wu Z; Zhu M; Yang X; Xu P; Wu S; Gao Z; Sun JL
    Front Immunol; 2023; 14():1083755. PubMed ID: 37180108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization to major Dermatophagoides pteronyssinus allergens in house dust mite allergic patients from North Eastern Poland developing rhinitis or asthma.
    Kowal K; Pampuch A; Siergiejko G; Siergiejko Z; Swiebocka E; Schlachter CR; Chruszcz M; Jacquet A
    Adv Med Sci; 2020 Sep; 65(2):304-309. PubMed ID: 32474401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between sensitization to house dust mite major allergens, age, and symptoms in Japanese house dust mite allergic subjects.
    Hasegawa A; Utsumi D; Lund K; Okano M; Ohashi-Doi K; Okubo K
    Int Immunopharmacol; 2022 Jun; 107():108640. PubMed ID: 35217338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cut-off value of D. pteronyssinus specific IgE in double negative patients Der p 1 and Der p 2 and its clinical repercussion.
    Letrán A; García I; Espinazo-Romeu M; Moreno-Aguilar C; Moreno F
    Sci Rep; 2021 Dec; 11(1):23585. PubMed ID: 34880341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Asthma and Sensitization to Allergens of Dermatophagoides pteronyssinus.
    Vidal C; Lojo S; Juangorena M; Gonzalez-Quintela A
    J Investig Allergol Clin Immunol; 2016; 26(5):304-309. PubMed ID: 27373988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression function against environmental dust exposure after Dermatophagoides pteronyssinus immunotherapy is associated with production of specific and cross-reactive immunoglobulin G4.
    Feng M; Luo T; Xian M; Shi X; Qin R; Zeng X; Su Q; Li J
    Clin Exp Allergy; 2022 Jul; 52(7):878-887. PubMed ID: 34962673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunological differences between asymptomatic HDM-sensitized and HDM-allergic rhinitis patients.
    Zidarn M; Robič M; Krivec A; Šilar M; Resch-Marat Y; Vrtala S; Kopač P; Bajrović N; Valenta R; Korošec P
    Clin Exp Allergy; 2019 Jun; 49(6):808-818. PubMed ID: 30734376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma, Airway Symptoms and Rhinitis in Office Workers in Malaysia: Associations with House Dust Mite (HDM) Allergy, Cat Allergy and Levels of House Dust Mite Allergens in Office Dust.
    Lim FL; Hashim Z; Than LT; Md Said S; Hisham Hashim J; Norbäck D
    PLoS One; 2015; 10(4):e0124905. PubMed ID: 25923543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgE recognition of the house dust mite allergen Der p 37 is associated with asthma.
    Huang HJ; Resch-Marat Y; Casset A; Weghofer M; Zieglmayer P; Zieglmayer R; Lemell P; Horak F; Chen KW; Potapova E; Matricardi PM; Pauli G; Grote M; Valenta R; Vrtala S
    J Allergy Clin Immunol; 2022 Mar; 149(3):1031-1043. PubMed ID: 34419535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy.
    Batard T; Baron-Bodo V; Martelet A; Le Mignon M; Lemoine P; Jain K; Mariano S; Horiot S; Chabre H; Harwanegg C; Marquette CA; Corgier BP; Soh WT; Satitsuksanoa P; Jacquet A; Chew FT; Nony E; Moingeon P
    Allergy; 2016 Feb; 71(2):220-9. PubMed ID: 26485347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinated IgG2 and IgE responses as a marker of allergen immunotherapy efficacy.
    Bordas-Le Floch V; Berjont N; Batard T; Varese N; O'Hehir RE; Canonica WG; van Zelm MC; Mascarell L
    Allergy; 2022 Apr; 77(4):1263-1273. PubMed ID: 34551124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Der f 23 as a new major allergen of Dermatophagoides farinae.
    He Y; Dou C; Su Y; Chen J; Zhang Z; Zhao Z; Chen J; Ji K
    Mol Med Rep; 2019 Aug; 20(2):1270-1278. PubMed ID: 31173194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.